DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) – Neurocrine Biosciences, Inc. Transaction History
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) portfolio value:
$160.66M
portfolio value
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -24.84% | -500K shares | -35.53M | $106.21 | 1.51M |
| Q2 2022 | share | Increase | +21.41% | 354.91K shares | 40.78M | $97.48 | 2.01M |
| Q1 2022 | share | Increase | +20.31% | 279.85K shares | 38.05M | $93.75 | 1.65M |
| Q4 2021 | share | Increase | +20.62% | 235.53K shares | 7.79M | $84.63 | 1.37M |
| Q3 2021 | share | Increase | +57.57% | 417.41K shares | 39.01M | $95.91 | 1.14M |
| Q2 2021 | share | 0.00% | 0 shares | 51K | $97.32 | 725K | |
| Q1 2021 | share | Increase | 0.00% | 725K shares | 70.50M | $97.25 | 725K |